Aurora Imaging Technology Receives FDA Clearance for Spectroscopy Technology

NORTH ANDOVER, MA. (Nov. 3, 2008) – Aurora Imaging Technology Inc. is proud to announce that the Aurora® 1.5Tesla Dedicated Breast MRI System has received 501(k) clearance from the U.S. Food and Drug Administration (FDA) for AuroraSPECTROSCOPY™, the company’s breast magnetic resonance (MR) spectroscopy package. The availability of AuroraSPECTROSCOPY will provide Aurora Breast MRI the capability to perform in vivo breast MR spectroscopy (MRS) and MR spectroscopic imaging (MRSI). AuroraSPECTROSCOPY was developed to supplement Aurora Breast MRI by further improving the image specificity of this groundbreaking technology. The Aurora Breast MRI remains the only FDA-cleared dedicated breast MRI system specifically designed for the detection, diagnosis and management of breast disease alone.

“The introduction of AuroraSPECTROSCOPY is another example of Aurora’s commitment to offering promising tools and technology to aid medical professionals in combating breast disease through early detection and improved treatment planning,” said Olivia Ho Cheng, president and chief executive officer, Aurora Imaging Technology.

sourceAurora Imaging